Spears Abacus Advisors LLC Merck & Co., Inc. Transaction History

Spears Abacus Advisors LLC

$4.73 Billion
Q3 2024

A detailed history of Spears Abacus Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 328,939 shares of MRK stock, worth $32.3 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

328,939

Previous 320,003 2.79%

Holding current value

$32.3 Million

Previous $39.6 Million 5.71%

% of portfolio

0.79%

Previous 0.86%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $993,236 - $1.15 Million	8,936 Added 2.79%	328,939 $37.4 Million
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $834,040 - $895,751	-6,737 Reduced 2.06%	320,003 $39.6 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $35.5 Million - $41.4 Million	313,871 Added 2438.97%	326,740 $43.1 Million
Q3 2023 Nov 21, 2023	SELL	$102.95 - $114.33 $82,360 - $91,464	-800 Reduced 5.85%	12,869 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $102,745 - $111,987	946 Added 7.44%	13,669 $1.58 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $29,852 - $33,309	290 Added 2.33%	12,723 $1.35 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $17,488 - $22,422	-200 Reduced 1.58%	12,433 $1.38 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $441,354 - $494,729	-6,004 Reduced 32.22%	12,633 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $439,390 - $550,392	6,079 Added 48.41%	18,637 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $21,504 - $23,649	-300 Reduced 2.33%	12,558 $943,000
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $17,225 - $19,053	245 Added 1.94%	12,858 $1 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $502,678 - $592,103	-7,300 Reduced 36.66%	12,613 $972,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $362,438 - $402,232	-5,050 Reduced 20.23%	19,913 $1.63 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $1,408 - $1,602	20 Added 0.08%	24,963 $1.93 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $65,260 - $90,454	-1,030 Reduced 3.97%	24,943 $1.92 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $99,069 - $111,788	1,277 Added 5.17%	25,973 $2.36 Million
Q2 2019 Aug 09, 2019	SELL	$69.84 - $81.59 $148,060 - $172,970	-2,120 Reduced 7.91%	24,696 $2.07 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $20,874 - $23,808	-300 Reduced 1.11%	26,816 $2.23 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $7,633 - $8,858	-117 Reduced 0.43%	27,116 $2.07 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $2,538 - $2,984	-44 Reduced 0.16%	27,233 $1.93 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $5,642 - $6,628	111 Added 0.41%	27,277 $1.66 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $63,363 - $68,180	1,080 Added 4.14%	27,166 $1.74 Million
Q2 2017 Aug 11, 2017	BUY	N/A	26,086	26,086 $1.67 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Account

Spears Abacus Advisors LLC Merck & Co., Inc. Transaction History